CY1105656T1 - Χρηση ανθρωπινου υποδοχεα προσομοιαζοντος με λατροφιλινη και συζευγμενου με g -πρωτεϊνη σε μεθοδους διαλογης - Google Patents

Χρηση ανθρωπινου υποδοχεα προσομοιαζοντος με λατροφιλινη και συζευγμενου με g -πρωτεϊνη σε μεθοδους διαλογης

Info

Publication number
CY1105656T1
CY1105656T1 CY20061101459T CY061101459T CY1105656T1 CY 1105656 T1 CY1105656 T1 CY 1105656T1 CY 20061101459 T CY20061101459 T CY 20061101459T CY 061101459 T CY061101459 T CY 061101459T CY 1105656 T1 CY1105656 T1 CY 1105656T1
Authority
CY
Cyprus
Prior art keywords
protein
human
receptor
latrofilin
mike
Prior art date
Application number
CY20061101459T
Other languages
Greek (el)
English (en)
Inventor
Shyam Ramakrishnan
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Publication of CY1105656T1 publication Critical patent/CY1105656T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CY20061101459T 2000-03-22 2006-10-12 Χρηση ανθρωπινου υποδοχεα προσομοιαζοντος με λατροφιλινη και συζευγμενου με g -πρωτεϊνη σε μεθοδους διαλογης CY1105656T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19110300P 2000-03-22 2000-03-22
US21074500P 2000-06-12 2000-06-12
PCT/EP2001/003223 WO2001070969A2 (en) 2000-03-22 2001-03-21 Regulation of human latrophilin-like g protein-coupled receptor

Publications (1)

Publication Number Publication Date
CY1105656T1 true CY1105656T1 (el) 2010-12-22

Family

ID=26886755

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20061101459T CY1105656T1 (el) 2000-03-22 2006-10-12 Χρηση ανθρωπινου υποδοχεα προσομοιαζοντος με λατροφιλινη και συζευγμενου με g -πρωτεϊνη σε μεθοδους διαλογης

Country Status (10)

Country Link
US (1) US20040175698A1 (de)
EP (1) EP1276867B1 (de)
AT (1) ATE337398T1 (de)
AU (1) AU2001263796A1 (de)
CY (1) CY1105656T1 (de)
DE (1) DE60122488T2 (de)
DK (1) DK1276867T3 (de)
ES (1) ES2271020T3 (de)
PT (1) PT1276867E (de)
WO (1) WO2001070969A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004018516A1 (en) * 2002-08-19 2004-03-04 Bayer Healthcare Ag Regulation of human secretin-type gpcr (latrophilin)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001229340A1 (en) * 2000-01-14 2001-07-24 Millennium Pharmaceuticals, Inc. Genes compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
US6436703B1 (en) * 2000-03-31 2002-08-20 Hyseq, Inc. Nucleic acids and polypeptides

Also Published As

Publication number Publication date
ES2271020T3 (es) 2007-04-16
PT1276867E (pt) 2006-12-29
WO2001070969A2 (en) 2001-09-27
DE60122488D1 (de) 2006-10-05
DK1276867T3 (da) 2007-01-02
WO2001070969A3 (en) 2002-09-26
DE60122488T2 (de) 2007-10-04
ATE337398T1 (de) 2006-09-15
AU2001263796A1 (en) 2001-10-03
US20040175698A1 (en) 2004-09-09
EP1276867B1 (de) 2006-08-23
EP1276867A2 (de) 2003-01-22

Similar Documents

Publication Publication Date Title
FI961251L (fi) Ihmisten metabotrooppiset glutamaattireseptorialatyypit(HMR4, HMR6, HMR7)ja niihin liittyvät DNA-yhdisteet
DK1047781T3 (da) IL-18-receptorer
CY1107133T1 (el) Κυκλικοι ανταγωνιστες των υποδοχεων c5a και συζευγμενοι με πρωτεϊνη g υποδοχεις
CY1108074T1 (el) Ανοσολογικες μεθοδοι για τη ρυθμιση της μυοστατινης σε σπονδυλωτα
SE9301667D0 (sv) New use
DK203489A (da) Anti-t-celle receptor determinanter til diagnosticering og behandling af autoimmune sygdomme
DE68915460D1 (de) Kopier-Dokumentenzuführvorrichtung mit verstellbarem Ausrichtungssystem, einstellbar durch den Benutzer.
CY1109543T1 (el) Βασικοι μη-πεπτιδικοι ανταγωνιστες βραδυκινινης και 5 φαρμακευτικες συνθεσεις απο αυτους
DK0733626T3 (da) N-(Benzofurazanyl)-arylsulfonamider og analoger deraf, der kan anvendes som endothelin-receptor-antagonister
ATE207118T1 (de) Hefe zellen so konstruiert, dass sie proteinsurrogate des pheromensystems produzieren und anwendungen dafuer
ATE259230T1 (de) Verwendung von vasopressin-antagonisten zur behandlung von störungen oder erkrankungen des innenohres
ATE431746T1 (de) Verwendung cd28 spezifischer monoklonaler antikörper zur stimulation von blutzellen, welche kein cd28 tragen
DK1141286T3 (da) Kæde af cytokinreceptorer
HUP0002985A2 (hu) Glicirrizinsavat és legalább egy antivirális hatású proteint tartalmazó vírusellenes gyógyszerkészítmény
ES2171196T3 (es) Uso de antagonistas del receptor cck-b para el tratamiento de trastornos del sueño.
DK1220852T3 (da) Substituerede diazepaner
DE59801230D1 (de) Endothelin-rezeptorantagonisten zur bekämpfung von hyperlipidämie
CY1105235T1 (el) Συνθεσεις λασοφοξιφενης
NZ326596A (en) Isolated vertebrate signalin gene peptide and use in intracellular signal transduction pathways mediated by TGF beta
BR9812368A (pt) 2-aminotetralinas, processo para sua preparação, e composições farmacêuticas, para a prevenção e tratamento terapêutico de patologias inflamatórias e/ou autoimunes
AUPN646795A0 (en) Neuropeptide Y-Y5 receptor
DE60122488D1 (de) Verwendung des menschlichen Latrophilin-like G Protein-coupled Receptor in Screenings-Verfahren
DE60313444D1 (de) Vegf-peptide und deren verwendung
NO20024779D0 (no) G-protein-koblet reseptor
EA199900253A1 (ru) Ptx-чувствительные g-протеины, их получение и применение